XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table displays our assets and liabilities measured on our consolidated balance sheets at fair value on a recurring basis as of March 31, 2023 and December 31, 2022.
Table 11.1: Assets and Liabilities Measured at Fair Value on a Recurring Basis
March 31, 2023
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$5,163 $0 $0 — $5,163 
RMBS0 66,104 247 — 66,351 
CMBS0 8,284 145 — 8,429 
Other securities188 1,794 0 — 1,982 
Total securities available for sale5,351 76,182 392 — 81,925 
Loans held for sale0 358 0 — 358 
Other assets:
Derivative assets(2)
523 1,292 837 $(1,026)1,626 
Other(3)
520 4 36 — 560 
Total assets$6,394 $77,836 $1,265 $(1,026)$84,469 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$526 $1,855 $819 $(636)$2,564 
Total liabilities$526 $1,855 $819 $(636)$2,564 
December 31, 2022
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$5,041 $$— $5,041 
RMBS62,353 236 — 62,589 
CMBS7,728 142 — 7,870 
Other securities186 1,233 — 1,419 
Total securities available for sale5,227 71,314 378 — 76,919 
Loans held for sale191 — 191 
Other assets:
Derivative assets(2)
474 2,545 79 $(1,134)1,964 
Other(3)
464 36 — 503 
Total assets$6,165 $74,053 $493 $(1,134)$79,577 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$823 $3,653 $74 $(1,235)$3,315 
Total liabilities$823 $3,653 $74 $(1,235)$3,315 
__________
(1)Represents balance sheet netting of derivative assets and liabilities, and related payables and receivables for cash collateral held or placed with the same counterparty. See “Note 8—Derivative Instruments and Hedging Activities” for additional information.
(2)Does not reflect $3 million and $4 million recognized as a net valuation allowance on derivative assets and liabilities for non-performance risk as of March 31, 2023 and December 31, 2022, respectively. Non-performance risk is included in the measurement of derivative assets and liabilities on our consolidated balance sheets, and is recorded through non-interest income in the consolidated statements of income.
(3)As of March 31, 2023 and December 31, 2022, other includes retained interests in securitizations of $36 million and $36 million, deferred compensation plan assets of $515 million and $453 million, and equity securities of $9 million (including unrealized gain of $0 million) and $14 million (including unrealized losses of $23 million), respectively.
Schedule of Level 3 Inputs Reconciliation
The table below presents a reconciliation for all assets and liabilities measured and recognized at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2023 and 2022. Generally, transfers into Level 3 were primarily driven by the usage of unobservable assumptions in the pricing of these financial instruments as evidenced by wider pricing variations among pricing vendors and transfers out of Level 3 were primarily driven by the usage of assumptions corroborated by market observable information as evidenced by tighter pricing among multiple pricing sources.
Table 11.2: Level 3 Recurring Fair Value Rollforward
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Three Months Ended March 31, 2023
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of
March 31, 2023(1)
(Dollars in millions)Balance, January 1, 2023
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, March 31, 2023
Securities available for sale:(2)
RMBS$236 $1 $3 $0 $0 $0 $(5)$34 $(22)$247 $2 
CMBS142 0 5 0 0 0 (2)0 0 145 0 
Total securities available for sale378 1 8 0 0 0 (7)34 (22)392 2 
Other assets:
Retained interests in securitizations36 0 0 0 0 0 0 0 0 36 0 
Net derivative assets (liabilities)(3)(4)
(5)0 0 0 104 12 (97)(1)18 4 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Three Months Ended March 31, 2022
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of March 31, 2022(1)
(Dollars in millions)Balance, January 1, 2022
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, March 31, 2022
Securities available for sale:(2)
RMBS$258 $10 $(12)$$$$(28)$12 $(29)$211 $
CMBS(1)13 21 (1)
Total securities available for sale267 10 (12)(29)25 (29)232 
Other assets:
Retained interests in securitizations41 (2)39 (2)
Net derivative assets (liabilities)(3)
19 28 (2)(28)22 
_________
(1)Realized gains (losses) on securities available for sale are included in net securities gains (losses) and retained interests in securitizations are reported as a component of non-interest income in our consolidated statements of income. Gains (losses) on derivatives are included as a component of net interest income or non-interest income in our consolidated statements of income.
(2)Net unrealized losses included in OCI related to Level 3 securities available for sale still held as of March 31, 2023 were $8 million. Net unrealized losses included in OCI related to Level 3 securities available for sale still held as of March 31, 2022 were $7 million.
(3)Includes derivative assets and liabilities of $837 million and $819 million, respectively, as of March 31, 2023 and $202 million and $180 million, respectively, as of March 31, 2022.
(4)Transfers into Level 3 primarily consist of term SOFR indexed interest rate derivatives.
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Quantitative Information
The following table presents the significant unobservable inputs used to determine the fair values of our Level 3 financial instruments on a recurring basis. We utilize multiple vendor pricing services to obtain fair value for our securities. Several of our vendor pricing services are only able to provide unobservable input information for a limited number of securities due to software licensing restrictions. Other vendor pricing services are able to provide unobservable input information for all securities for which they provide a valuation. As a result, the unobservable input information for the securities available for sale presented below represents a composite summary of all information we are able to obtain. The unobservable input information for all other Level 3 financial instruments is based on the assumptions used in our internal valuation models.
Table 11.3: Quantitative Information about Level 3 Fair Value Measurements
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
March 31,
2023
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$247 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
4-17%
1-15%
0-11%
30-80%
6%
8%
2%
57%
CMBS145 Discounted cash flows (vendor pricing)Yield
4-6%
5%
Other assets:
Retained interests in securitizations(2)
36 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
32-45
9-16%
5-8%
2%
45-163%
N/A
Net derivative assets (liabilities)18 Discounted cash flowsSwap rates
3-5%
3%
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
December 31,
2022
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$236 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
3-12%
4-20%
0-11%
30-80%
7%
8%
2%
58%
CMBS142 Discounted cash flows (vendor pricing)Yield
4-5%
5%
Other assets:
Retained interests in securitizations(2)
36 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
30-43
9-18%
4-7%
1%
62-291%
N/A
Net derivative assets (liabilities)Discounted cash flowsSwap rates
3-4%
4%
__________
(1)Weighted averages are calculated by using the product of the input multiplied by the relative fair value of the instruments.
(2)Due to the nature of the various mortgage securitization structures in which we have retained interests, it is not meaningful to present a consolidated weighted average for the significant unobservable inputs.
Schedule of Assets Measured at Fair Value on Nonrecurring Basis
The following table presents the carrying value of the assets measured at fair value on a nonrecurring basis and still held as of March 31, 2023 and December 31, 2022, and for which a nonrecurring fair value measurement was recorded during the three and twelve months then ended.
Table 11.4: Nonrecurring Fair Value Measurements
March 31, 2023
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$0 $204 $204 
Other assets(1)
0 51 51 
Total$0 $255 $255 
December 31, 2022
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$$284 $284 
Loans held for sale11 11 
Other assets(1)
220 220 
Total$11 $504 $515 
__________
(1)As of March 31, 2023, other assets included investments accounted for under measurement alternative of $6 million and repossessed assets of $45 million. As of December 31, 2022, other assets included investments accounted for under measurement alternative of $4 million, cost method investments of $3 million, repossessed assets of $55 million and long-lived assets held for sale and right-of-use assets totaling $158 million.
Schedule of Earnings Related to Assets Measured at Fair Value on Nonrecurring Basis
The following table presents total nonrecurring fair value measurements for the period, included in earnings, attributable to the change in fair value relating to assets that are still held at March 31, 2023 and 2022.
Table 11.5: Nonrecurring Fair Value Measurements Included in Earnings
Total Gains (Losses)
Three Months Ended March 31,
(Dollars in millions)20232022
Loans held for investment$(105)$(14)
Other assets(1)
(37)(19)
Total$(142)$(33)
__________
(1)Other assets include fair value adjustments related to repossessed assets, long-lived assets held for sale and right-of-use assets, and equity investments accounted for under the measurement alternative.
Schedule of Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value, including the level within the fair value hierarchy, of our financial instruments that are not measured at fair value on a recurring basis on our consolidated balance sheets as of March 31, 2023 and December 31, 2022.
Table 11.6: Fair Value of Financial Instruments
March 31, 2023
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$46,513 $46,513 $3,347 $43,166 $0 
Restricted cash for securitization investors460 460 460 0 0 
Net loans held for investment294,518 300,206 0 0 300,206 
Loans held for sale5 5 0 5 0 
Interest receivable2,250 2,250 0 2,250 0 
Other investments(1)
1,327 1,327 0 1,327 0 
Financial liabilities:
Deposits with defined maturities76,044 75,495 0 75,495 0 
Securitized debt obligations17,813 17,737 0 17,737 0 
Senior and subordinated notes30,398 29,585 0 29,585 0 
Federal funds purchased and securities loaned or sold under agreements to repurchase542 542 0 542 0 
Interest payable621 621 0 621 0 
 December 31, 2022
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$30,856 $30,856 $5,193 $25,663 $
Restricted cash for securitization investors400 400 400 
Net loans held for investment299,091 302,920 302,920 
Loans held for sale11 11 11 
Interest receivable2,104 2,104 2,104 
Other investments(1)
1,326 1,326 1,326 
Financial liabilities:
Deposits with defined maturities45,858 45,531 45,531 
Securitized debt obligations16,973 16,918 16,918 
Senior and subordinated notes30,826 30,744 30,744 
Federal funds purchased and securities loaned or sold under agreements to repurchase883 883 883 
Interest payable527 527 527 
__________
(1)Other investments include FHLB and Federal Reserve stock. These investments are included in other assets on our consolidated balance sheets.